Bacterial Enteric Infections Flashcards

1
Q

What factors may increase the risk of enteric bacterial infections in individuals with HIV?

A

HIV-associated alterations in mucosal immunity, intestinal integrity, and treatment with acid-suppressive agents

Rates of Gram-negative bacterial enteric infections are at least 10 times higher among adults with HIV than in the general population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which bacteria are most frequently isolated by culture from adults with HIV in the United States?

A
  • Shigella
  • Campylobacter
  • nontyphoidal Salmonella spp.

Particularly Salmonella enterica serotypes Typhimurium and Enteritidis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the relationship between CD4 T lymphocyte count and the risk of bacterial diarrhea in individuals with HIV?

A

The risk of bacterial diarrhea is greatest in individuals with clinical AIDS or CD4 counts <200 cells/mm3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a common condition associated with Clostridioides difficile in people with HIV?

A

Clostridioides difficile–associated infection (CDI)

Low CD4 count (<50 cells/mm3) is an independent risk factor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What defines severe community-associated diarrhea in people with HIV?

A

Six or more loose stools per day with or without other signs of systemic illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the recommended method for diagnosing Gram-negative bacterial enteric infections?

A

Cultures of stool and blood or stool molecular methods (culture-independent diagnostic tests).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the significance of obtaining blood cultures in patients with diarrhea and fever in the context of HIV?

A

High incidence of bacteremia associated with Salmonella gastroenteritis in people with HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of endoscopy in diagnosing enteric infections in people with HIV?

A

Reserved for cases where stool culture, microscopy, and other tests fail to reveal an etiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What precautions should be taken to prevent enteric infections in individuals with HIV?

A
  • Wash hands regularly with soap and water
  • Use of barriers during sexual practices
  • Avoid contact with human feces

Soap and water are preferred over alcohol-based cleansers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What immunizations are recommended for travelers at risk of bacterial enteric infections?

A

Immunizations against Salmonella serotype Typhi.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the recommended treatment for people with HIV and CD4 count 200–500 cells/mm3 experiencing diarrhea?

A
  • Azithromycin 500 mg PO daily for 5 days
  • Ciprofloxacin 500–750 mg PO every 12 hours for 5 days.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a key consideration when treating bacterial enteric infections in people with HIV?

A

Diagnostic fecal specimens should be obtained before initiation of empiric antimicrobial therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fill in the blank: The risk of a bacterial enteric infection increases as CD4 count ______.

A

<200 cells/mm3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What should be considered if no clinical response occurs after 3 to 4 days of therapy for bacterial enteric infections?

A

Follow-up stool culture with antibiotic susceptibility testing and other methods to detect enteric pathogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: Antimicrobial prophylaxis to prevent bacterial enteric illness is routinely recommended for travelers.

A

False.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the potential adverse effects of routine use of fluoroquinolones for prophylaxis in enteric infections?

A

Toxicity associated with CDI and increasing rates of antimicrobial resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the preferred agent for prophylaxis in pregnant people traveling to areas at risk for bacterial enteric infections?

A

Azithromycin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What clinical syndromes are associated with Gram-negative enteric bacteria among people with HIV?

A
  • Self-limited gastroenteritis
  • Severe and prolonged diarrheal disease
  • Bacteremia with or without gastrointestinal illness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should be included in the assessment of patients with diarrhea in the context of HIV?

A

Complete exposure history, medication review, stool frequency and consistency, associated signs and symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the importance of reflex stool cultures and antibiotic sensitivity testing?

A

To address increasing resistance detected in enteric bacterial infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the definition of diarrhea for testing C. difficile infection (CDI)?

A

Three or more loose stools in 24 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the initial treatment for suspected bacteremia in patients with HIV?

A

Ceftriaxone 1–2 g IV every 24 hours until susceptibility results are available

This treatment can be adjusted based on sensitivity results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When is a carbapenem preferred for empiric therapy?

A

When Campylobacter or Shigella bacteremia is suspected

This is to ensure effective treatment in potentially resistant cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the recommended duration of therapy if no pathogen is identified and the patient recovers quickly?

A

5 days of therapy is recommended

This duration may vary based on stool microbiology results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the increased risk of bacteremia in patients with HIV and salmonellosis?

A

20- to 100-fold increased risk

Mortality can be increased by as much as sevenfold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the preferred therapy for Nontyphoidal Salmonella gastroenteritis if susceptible?

A

Ciprofloxacin 500–750 mg PO (or 400 mg IV) every 12 hours

This is the first-line treatment for susceptible cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What should be the duration of therapy for gastroenteritis without bacteremia in patients with CD4 count ≥200 cells/mm3?

A

7–14 days

Duration may extend depending on patient conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the recommended therapy for gastroenteritis with bacteremia in patients with CD4 count <200 cells/mm3?

A

2–6 weeks of therapy

The duration may be longer if the infection is complicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Is secondary prophylaxis for recurrent bacteremia or gastroenteritis well established?

A

No, it is not well established

Clinicians must weigh the benefits against the risks of long-term antibiotic exposure.

30
Q

What is the preferred initial therapy for Shigellosis if the patient is severely ill?

A

Initiate a carbapenem while awaiting susceptibility results

This approach is to ensure effective treatment during critical situations.

31
Q

What is the recommended duration of therapy for Shigellosis gastroenteritis?

A

5–7 days

Ciprofloxacin may be given for 5 to 10 days if susceptible.

32
Q

What is the first-line therapy for Clostridioides difficile–associated infection?

A

Fidaxomicin 200 mg PO two times per day for 10 days

This is the preferred treatment for CDI.

33
Q

What alternative therapy can be used for nonsevere CDI?

A

Metronidazole 500 mg PO three times per day for 10 days

This is recommended if fidaxomicin or vancomycin is unavailable.

34
Q

What should be avoided in the first trimester of pregnancy regarding antibiotic use?

A

TMP-SMX should be avoided if possible

It is associated with increased risk of birth defects.

35
Q

What is the recommended therapy for mild Campylobacteriosis if diarrhea resolves before culture confirmation?

A

Antibiotic treatment can be withheld

If symptoms persist, consider antibiotic therapy.

36
Q

What is the duration of therapy for bacteremia in Campylobacteriosis?

A

≥14 days

This is critical for effective management.

37
Q

What should be considered for chronic maintenance or suppressive therapy for Shigella infections?

A

Not recommended for first-time Shigella infections

This approach helps prevent unnecessary long-term antibiotic use.

38
Q

What is the role of ART in patients with recurrent bacteremia or gastroenteritis?

A

HIV suppression with ART is expected to decrease the risk of recurrent illnesses

ART helps manage HIV effectively.

39
Q

What is the effect of diarrhea on temporary malabsorption in patients with HIV?

A

Diarrhea can produce temporary malabsorption or lactose intolerance

A bland diet is recommended to alleviate symptoms.

40
Q

What is the treatment of choice for susceptible nontyphoidal Salmonella spp. infection?

A

Fluoroquinolone, preferably ciprofloxacin

Alternatives include levofloxacin and moxifloxacin.

41
Q

What is recommended if invasive disease is suspected or confirmed in nontyphoidal Salmonella infection?

A

Ceftriaxone over ciprofloxacin

Recommended until susceptibilities return.

42
Q

What is the recommended treatment duration for patients with CD4 counts ≥200 cells/mm3 and mild gastroenteritis from Salmonella?

A

7 to 14 days

If bacteremia is present, 14 days is appropriate.

43
Q

For patients with advanced HIV disease and Salmonella infection, what is the minimum recommended treatment duration?

A

2 weeks, extendable up to 6 weeks

Especially in severe disease or bacteremia.

44
Q

True or False: Secondary prophylaxis should be considered for patients with recurrent Salmonella bacteremia.

A

True

Also considered for patients with recurrent gastroenteritis.

45
Q

What should be monitored in people with HIV and Salmonella bacteremia after treatment?

A

Clinical recurrence

Recurrence may present as bacteremia or localized infection.

46
Q

What is the preferred treatment for susceptible Shigella infections?

A

Fluoroquinolone, preferably ciprofloxacin

Treatment duration is typically 5 to 10 days.

47
Q

What percentage of Shigella spp. isolated in the U.S. in 2023 harbored genetic markers of resistance to ciprofloxacin?

A

60%

Azithromycin resistance was also reported at 34%.

48
Q

What is the recommended treatment for Campylobacter bacteremia?

A

At least 14 days with a fluoroquinolone if sensitive

Azithromycin is not recommended for Campylobacter bacteremia.

49
Q

Fill in the blank: The treatment of CDI in people with HIV is _______.

A

the same as in people without HIV

Available data suggest similar responses to treatment.

50
Q

What is the recommended treatment for an initial episode of CDI?

A

Fidaxomicin rather than oral vancomycin

Both treatments are acceptable, but fidaxomicin is preferred.

51
Q

What monoclonal antibody is approved for prevention of recurrent CDI?

A

Bezlotoxumab

It is used in conjunction with standard antibiotic therapy.

52
Q

What should be considered when initiating ART in the presence of an enteric infection?

A

Initiation should not be delayed

It is relevant only for the patient’s ability to absorb ART.

53
Q

What is recommended for monitoring patients after treatment for enteric infections?

A

Monitor for improvement in symptoms and resolution of diarrhea

Follow-up stool testing may be required in certain cases.

54
Q

What is the risk factor for CDI recurrence?

A

Age ≥65 years, history of CDI, compromised immunity

Severe CDI and certain virulent strains also increase risk.

55
Q

What should be done if recurrent enteric infections are documented?

A

Prompt initiation of ART should be considered

This applies regardless of CD4 count.

56
Q

What should be avoided when coadministering fluoroquinolones?

A

Magnesium- or aluminum-containing antacids

These agents interfere with fluoroquinolone absorption.

57
Q

What should be considered when treating ic infections in patients with HIV?

A

The patient’s immune status, exposures, and the possibility of C. difficile or antimicrobial resistance

Observational studies indicate a connection between severe diarrhea or malabsorption and decreased plasma drug concentrations in people with HIV.

58
Q

What should be avoided when coadministering fluoroquinolones?

A

Magnesium- or aluminum-containing antacids, calcium, zinc, or iron

These agents interfere with fluoroquinolone absorption.

59
Q

What is the recommendation for using antibiotics in clinically unstable patients?

A

Use IV antibiotics

This is suggested due to the potential impact of severe diarrhea on antibiotic absorption.

60
Q

Has immune reconstitution inflammatory syndrome been described with typical bacterial enteric pathogens treatment?

61
Q

What is a pharmacologic approach for preventing recurrent enteric infections?

A

Consider secondary prophylaxis for recurrent Salmonella bacteremia, recurrent shigellosis, or campylobacteriosis

This is outlined in the section on directed therapy for each bacterial species.

62
Q

What is the first-line therapy for bacterial enteric infections during pregnancy?

A

Expanded-spectrum cephalosporins or azithromycin

This depends on the organism and susceptibility testing results.

63
Q

What risk has been noted with quinolone use during pregnancy?

A

Arthropathy in offspring of animals treated with quinolones

However, studies in humans did not find increased birth defect risks.

64
Q

What should be avoided in the first trimester of pregnancy?

A

TMP-SMX use

This is due to its association with increased risk of birth defects.

65
Q

What is recommended for individuals on TMP-SMX prior to or during early pregnancy?

A

Supplemental folic acid 4 mg/day

This should be given to those capable of becoming pregnant.

66
Q

What should neonatal care providers be informed about regarding maternal sulfa therapy?

A

The use of sulfa therapy near delivery due to the risk of hyperbilirubinemia and kernicterus in the newborn.

67
Q

Can oral rifaximin and fidaxomicin be used in pregnancy?

A

Yes

These are not absorbed systemically.

68
Q

What is the use of intravenous vancomycin in the perinatal period?

A

Intrapartum prophylaxis in penicillin allergic patients colonized with group B streptococcus.

69
Q

What should be noted about oral vancomycin for enteric disease?

A

It is recommended only in its oral formulation, which is not absorbed systemically

Intravenous vancomycin crosses the placenta.

70
Q

What did a study find regarding infants exposed to maternal intravenous vancomycin therapy?

A

No hearing loss or renal toxicity was attributed to vancomycin.

71
Q

What was the finding regarding metronidazole use in pregnancy?

A

No increase in risk of birth defects was found

This was for treatment of trichomoniasis or bacterial vaginosis.

72
Q

Have studies been found on metronidazole for CDI in pregnancy?